Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiRNA: key host-microbiota modulators and therapeutic targets in Inflammatory Bowel disease

ABSTRACT: miRNA: key host-microbiota modulators and therapeutic targets in Inflammatory Bowel disease

PROVIDER: PRJEB66130 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12049100_1.fastq.gz	Fastqsanger.gz
	ERR12049100_2.fastq.gz	Fastqsanger.gz
	ERR12049200_1.fastq.gz	Fastqsanger.gz
	ERR12049200_2.fastq.gz	Fastqsanger.gz
	ERR12049300_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 768

Similar Datasets

Mitochondria as key therapeutic targets for the treatment of corneal fibrosis

Project description:Mitochondria as key therapeutic targets for the treatment of corneal fibrosis

| PRJNA967702 | ENA

MAT2A as key regulator and therapeutic target in MLL leukemogenesis

Project description:MAT2A as key regulator and therapeutic target in MLL leukemogenesis

| PRJNA594944 | ENA

Epigenetic modulators as therapeutic targets in prostate cancer.

Project description:Prostate cancer is one of the most common non-cutaneous malignancies among men worldwide. Epigenetic aberrations, including changes in DNA methylation patterns and/or histone modifications, are key drivers of prostate carcinogenesis. These epigenetic defects might be due to deregulated function and/or expression of the epigenetic machinery, affecting the expression of several important genes. Remarkably, epigenetic modifications are reversible and numerous compounds that target the epigenetic enzymes and regulatory proteins were reported to be effective in cancer growth control. In fact, some of these drugs are already being tested in clinical trials. This review discusses the most important epigenetic alterations in prostate cancer, highlighting the role of epigenetic modulating compounds in pre-clinical and clinical trials as potential therapeutic agents for prostate cancer management.

| S-EPMC5025578 | biostudies-literature

IDENTIFYING KEY DRIVER GENES OF INNATE IMMUNE PATHWAYS AS NOVEL THERAPEUTIC TARGETS IN RENAL ALLOGRAFT REJECTION

Project description:IDENTIFYING KEY DRIVER GENES OF INNATE IMMUNE PATHWAYS AS NOVEL THERAPEUTIC TARGETS IN RENAL ALLOGRAFT REJECTION

| PRJNA574297 | ENA

Functional screen of Inflammatory bowel disease genes reveals key epithelial functions: Agilent Targeted Dataset

Project description:Functional screen of Inflammatory bowel disease genes reveals key epithelial functions: Agilent Targeted Dataset

| PRJNA771679 | ENA

Thrombospondin-1 type 1 repeats in a model of inflammatory bowel disease: genetic profile and therapeutic effects

Project description:Thrombospondin 1 (TSP-1) is an anti-angiogenic matricellular protein with regulatory functions in inflammation and cancer. The type 1 repeats (TSR) domains of TSP-1 have been shown to interact with a wide range of proteins that result in the anti-angiogenic and anti-tumor properties of TSP-1. To evaluate potential therapeutic effects of TSRs in inflammatory bowel disease, we conducted clinical, histological and gene microarray analyses on a mouse model of induced colitis. We used Affymetrix GeneChips to determine the changes in the genetic profile underlying TSR-treatment coincident with induction of colitis using DSS. We identified differentially expressed genes among the treatment groups. Using DSS (dextran sulfate sodium) to induce colitis, wild-type mice were simultaneously injected with either saline or one form of TSP-1 derived peptides, containing either the three domains of the TSR (3TSR), the two last domains (TSR2), or TSR2 with the RFK sequence (TSR2+RFK). Wt mice drinking water only was used as reference.

2014-08-26 | E-GEOD-32697 | biostudies-arrayexpress

Assessing the mechanism and therapeutic potential of modulators of the human mediator complex-associated protein kinases

Project description:Assessing the mechanism and therapeutic potential of modulators of the human mediator complex-associated protein kinases

| PRJNA319014 | ENA

IDENTIFYING KEY DRIVER GENES OF INNATE IMMUNE PATHWAYS AS NOVEL THERAPEUTIC TARGETS IN RENAL ALLOGRAFT REJECTION

Project description:Acute rejection (AR) in renal transplantation is an established risk factor for reduced allograft survival, and still occurs in 10-20% of allograft recipients despite standard of care immunosuppression. This suggests molecular pathways exist which are inadequately suppressed by current therapy. We describe for the first time, integrative network- based computational strategies incorporating genotyping data to identify key driver genes (KDGs) amongst networks of perturbed transcripts in AR, which may serve as therapeutic targets.

2020-11-03 | GSE138043 | GEO

Nematode Orthologs of Macrophage Migration Inhibitory Factor (MIF) as Modulators of the Host Immune Response and Potential Therapeutic Targets.

Project description:One of the adaptations of nematodes, which allows long-term survival in the host, is the production of proteins with immunomodulatory properties. The parasites secrete numerous homologs of human immune mediators, such as macrophage migration inhibitory factor (MIF), which is a substantial regulator of the inflammatory immune response. Homologs of mammalian MIF have been recognized in many species of nematode parasites, but their role has not been fully understood. The application of molecular biology and genetic engineering methods, including the production of recombinant proteins, has enabled better characterization of their structure and properties. This review provides insight into the current state of knowledge on MIF homologs produced by nematodes, as well as their structure, enzymatic activity, tissue expression pattern, impact on the host immune system, and potential use in the treatment of parasitic, inflammatory, and autoimmune diseases.

| S-EPMC8877345 | biostudies-literature

Small bowel metagenome

Project description:Small Bowel Metagenome

| PRJNA590519 | ENA